Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

PolandBack to Poland

Clinical trials in Siemianowice Slaskie

12 clinical trials in Siemianowice Slaskie, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Siemianowice Slaskie at a glance
12
clinical trials
  • Not yet recruiting0
  • Research sites0
Type of trial
Recruitment status
Quick filters

12 trials in Siemianowice Slaskie

Open in trial search

Skin ulcer

Recruiting

Study on the Effectiveness of EscharEx and Amnion/Chorion Membrane Allograft for Patients with Venous Leg Ulcers

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Concentrate of proteolytic enzymes enriched in bromelain
  • Sponsor:Mediwound Ltd.

Varicella

Recruiting

Study of new chickenpox vaccine and measles-mumps-rubella vaccine given by intramuscular injection in healthy children aged 12 to 15 months

Registered drugNo placebo
Countries:PolandPoland
  • Participants:0–17 years · Healthy volunteers
  • Substances:GSKVX000000025896
  • Sponsor:GlaxoSmithKline Biologicals

Varicella

Recruiting

Study on the Immune Response and Safety of a New Varicella Vaccine (GSKVX000000025896) Compared to Varicella Virus Oka/Merck Strain in Healthy Children Aged 12-15 Months

Registered drugNo placebo
Countries:PolandPoland
  • Participants:0–17 years · Healthy volunteers
  • Substances:GSKVX000000025896
  • Sponsor:GlaxoSmithKline Biologicals

Influenza

Recruiting

Study on Baloxavir Marboxil for Children with Influenza

Registered drugNo placebo
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Baloxavir Marboxil
  • Sponsor:F. Hoffmann-La Roche AG

Dementia Alzheimer's type

Not recruiting

Study on Donanemab, Florbetapir, and Flortaucipir for Patients with Early Alzheimer's Disease

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Donanemab
  • Sponsor:Eli Lilly & Co.

Meningococcal immunisation

Not recruiting

Safety and immunogenicity study of Pentavalent Meningococcal ABCYW vaccine (MenPenta SD and MenPenta fHD) compared to licensed meningococcal vaccines in infants, toddlers and children

Registered drugNo placebo
Countries:PolandPoland
  • Participants:0–17 years · Healthy volunteers
  • Substances:Diphtheria toxoid
  • Sponsor:Sanofi Vaccines US Inc.

Meningitis meningococcal

Not recruiting

Study on the Safety and Immune Response of MenABCWY Vaccine and Drug Combination in Healthy Infants with Meningococcal Infections

Registered drugNo placebo
Countries:PolandPoland
  • Participants:0–17 years · Healthy volunteers
  • Substances:GSKVX000000017986
  • Sponsor:GlaxoSmithKline Biologicals

Pneumococcal immunisation

Not recruiting

Study on the Safety and Immune Response of a 21-Valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers

Registered drugNo placebo
Countries:PolandPoland
  • Participants:0–17 years · Healthy volunteers
  • Substances:Pneumococcal oligosaccharide serotype 18C conjugated to CRM197
  • Sponsor:Sanofi Vaccines US Inc.

Pneumococcal infection

Not recruiting

Study on the Safety and Immune Response of PF-07831695 and a Drug Combination for Pneumococcal Infections in Healthy Toddlers Aged 12-15 Months

Registered drugNo placebo
Countries:PolandPoland
  • Participants:0–17 years · Healthy volunteers
  • Substances:PF-07831695
  • Sponsor:Pfizer Inc.

Meningococcal infection

Not recruiting

Study on the Safety and Immune Response of MenACYW Conjugate Vaccine Compared to a Drug Combination in Healthy Infants and Toddlers

Registered drugNo placebo
Countries:PolandPoland
  • Participants:0–17 years · Healthy volunteers
  • Substances:N. Meningitidis Group C (Strain C11) Polysaccharide (De-O-Acetylated) Conjugated To Tetanus Toxoid
  • Sponsor:Sanofi Pasteur

Study on OM-85 for Preventing Respiratory Infections in Children with Wheezing Illness (Ages 6 Months to 5 Years)

Not recruiting
Registered drug
Countries:PolandPoland
  • Participants:0–17 years
  • Sponsor:OM Pharma SA

Orthostatic hypotension

Not recruiting

Study on Ampreloxetine and Midodrine Hydrochloride for Treating Neurogenic Orthostatic Hypotension in Patients with Multiple System Atrophy

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ampreloxetine
  • Sponsor:Theravance Biopharma Ireland Limited

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Siemianowice Slaskie

What the registry says about research in the country

01 Pediatric Infectious Disease Prevention

Groundbreaking research focusing on vaccine development for common childhood infections, including studies of new formulations for chickenpox and meningococcal prevention in infants and toddlers.

  • Varicella vaccine immunogenicity
  • Meningococcal ACYW protection
  • Pneumococcal prevention

These trials aim to enhance vaccine safety profiles and immune response in young populations.

02 Respiratory Health Research

Innovative studies targeting respiratory tract infections and influenza, with particular attention to treatment resistance and therapeutic interventions for pediatric patients.

  • Influenza treatment effectiveness
  • Recurrent respiratory infections
  • Wheezing illness management

Research focuses on both preventive measures and therapeutic approaches for respiratory conditions.

03 Neurodegenerative Disease Studies

Advanced clinical research exploring treatments for Alzheimer's disease and related conditions, including innovative approaches to managing psychosis and neurological symptoms.

  • Early-stage Alzheimer's treatment
  • Psychosis management
  • Neurogenic orthostatic hypotension

These trials evaluate novel therapeutic approaches for complex neurological conditions.

Back to PolandAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.